Sobi - Transforming the lives of people with rare diseases At Sobi, we are dedicated to transforming the lives of people with rare and debilitating diseases Meet some of the people who inspire us Their real-life experiences and stories reinforce our commitment to patients
Sobi in Middle East | Focus on Rare Diseases Sobi in the Middle East is dedicated to developing and delivering innovative treatments that improve the lives of people living with rare diseases
Sobi | Sobi France Sobi est une société biopharmaceutique internationale spécialisée dans les maladies rares Nous nous engageons à fournir un accès à des traitements innovants qui transforment la vie des personnes atteintes de maladies rares
Pipeline - Sobi Explore Sobi's innovative pipeline for covering a range of treatments in diverse therapeutic areas
Careers - Sobi At Sobi, we are transforming the lives of people living with rare and debilitating diseases By turning research into innovative treatments – in collaboration with patient organisations, healthcare professionals and government authorities – we help make medicine more accessible, opening up more possibilities for people living with rare
Who We Are | Sobi North America - Sobi United States At Sobi North America, we are inspired by a single vision – to be recognized as a global leader in providing innovative medicines that transform the lives of people with rare and debilitating diseases
Medicines - Sobi * Sobi and Sanofi collaborate on the development and commercialisation of Alprolix, Elocta Eloctate and ALTUVOCT ** Sobi and Apellis have global co-development rights for systemic pegcetacoplan Sobi has exclusive ex-US commercialization rights for systemic pegcetacoplan, and Apellis has exclusive US commercialisation rights for systemic